Mental disorders as risk factors for type 2 diabetes: an umbrella review with policy implications
Abstract
Background: Improving our understanding of modifiable risk factors for type 2 diabetes (T2D) is essential for strengthening primary prevention. Treatable mental disorders have increasingly attracted attention in this area, highlighting a shift from a single-disease approach to a multimorbidity perspective. We conducted an umbrella review to evaluate the scope, consistency, and strength of the available evidence.
Methods: Meta-analyses, cohort studies (not included in meta-analyses) and Mendelian randomization studies (MRS) published through 03/2026 were identified via the main biomedical databases, supplemented by manual searches. Eligibility criteria included: adults free of diabetes at baseline, incident T2D assessed after baseline measurement of anxiety, depressive or sleep disorders.
Results: For anxiety disorders, risk estimates from meta-analyses (N = 2) ranged from 1.19 to 1.34; from MRS (N = 2) the range was 1.05 - 1.15; from cohort studies (N = 11) the range was 0.73 - 2.30. For depressive disorders, risk estimates from meta-analyses (N = 9) ranged from 1.08 to 1.67; from MRS (N = 3) from 0.96 to 1.33; from cohort studies (N = 22) from 0.50 to 3.93. For sleep disorders/insomnia, risk estimates from meta-analyses (N = 3) ranged from 1.38 to 2.29; from MRS (N = 9) the range was 0.15 - 1.89; from cohort studies (N = 17) the range was 0.96 - 2.64. This literature is characterized by methodological heterogeneity regarding study populations, measurement tools, follow-up duration, and covariate adjustment.
Conclusions: Multiple meta-analyses provide convincing evidence for mental disorders as independent risk factors for incident T2D. Depressive disorders have been the most extensively studied mental disorders in this domain. The findings support greater integration of mental health into T2D prevention strategies and highlight the need for adopting a multimorbidity perspective in research, clinical settings, and policy.
Key messages: • Multimorbidity requires a paradigm shift away from a single-disease model in order to develop better primary and secondary prevention.
• Mental-physical multimorbidity impacts individuals of all ages and has implications for healthcare, research and policy.
Related
- Interventions for Cognitive Impairment in Type 2 Diabetes Mellitus: An Umbrella Review of Pharmacological and Lifestyle Strategies, Mechanisms, and Clinical Implications
- Metabolic dysfunction-associated steatotic liver disease and neurocognitive and reward circuit dysfunction: implications for mental disorders
- Prevalence and risk factors of mental disorders in a cross-sectional study of adolescents in South China.
- Meta-analysis on risk factors for mental disorders after exposure to natur al hazards
- Testing implications of the network theory of mental disorders in intensive short-term treatment
BibTeX
@article{andreeva2026mental,
title = {{Mental disorders as risk factors for type 2 diabetes: an umbrella review with policy implications}},
author = {V A Andreeva and P Duquenne and T R D’Aoust and M C Brindisi and S Chambaron and C Samieri and M Touvier and L K Fezeu},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.1068},
url = {https://doi.org/10.1093/eurpub/ckag169.1068},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Mental disorders as risk factors for type 2 diabetes: an umbrella review with policy implications
AU - V A Andreeva
AU - P Duquenne
AU - T R D’Aoust
AU - M C Brindisi
AU - S Chambaron
AU - C Samieri
AU - M Touvier
AU - L K Fezeu
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.1068
UR - https://doi.org/10.1093/eurpub/ckag169.1068
AB - Background: Improving our understanding of modifiable risk factors for type 2 diabetes (T2D) is essential for strengthening primary prevention. Treatable mental disorders have increasingly attracted attention in this area, highlighting a shift from a single-disease approach to a multimorbidity perspective. We conducted an umbrella review to evaluate the scope, consistency, and strength of the available evidence. Methods: Meta-analyses, cohort studies (not included in meta-analyses) and Mendelian randomization studies (MRS) published through 03/2026 were identified via the main biomedical databases, supplemented by manual searches. Eligibility criteria included: adults free of diabetes at baseline, incident T2D assessed after baseline measurement of anxiety, depressive or sleep disorders. Results: For anxiety disorders, risk estimates from meta-analyses (N = 2) ranged from 1.19 to 1.34; from MRS (N = 2) the range was 1.05 - 1.15; from cohort studies (N = 11) the range was 0.73 - 2.30. For depressive disorders, risk estimates from meta-analyses (N = 9) ranged from 1.08 to 1.67; from MRS (N = 3) from 0.96 to 1.33; from cohort studies (N = 22) from 0.50 to 3.93. For sleep disorders/insomnia, risk estimates from meta-analyses (N = 3) ranged from 1.38 to 2.29; from MRS (N = 9) the range was 0.15 - 1.89; from cohort studies (N = 17) the range was 0.96 - 2.64. This literature is characterized by methodological heterogeneity regarding study populations, measurement tools, follow-up duration, and covariate adjustment. Conclusions: Multiple meta-analyses provide convincing evidence for mental disorders as independent risk factors for incident T2D. Depressive disorders have been the most extensively studied mental disorders in this domain. The findings support greater integration of mental health into T2D prevention strategies and highlight the need for adopting a multimorbidity perspective in research, clinical settings, and policy. Key messages: • Multimorbidity requires a paradigm shift away from a single-disease model in order to develop better primary and secondary prevention. • Mental-physical multimorbidity impacts individuals of all ages and has implications for healthcare, research and policy.
SN - 1101-1262
SN - 1464-360X
ER -